S 4355
Drug Deal Disclosure Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:31 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Drug Deal Disclosure Act requires the Department of Health and Human Services to publicly release detailed information about private drug pricing agreements between the federal government and pharmaceutical manufacturers. This includes agreements that offer reduced prices based on international benchmarks, direct-to-consumer sales deals, or other preferential treatment. The goal is to increase transparency in drug pricing and assess the economic impact of these agreements on the healthcare system.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.